huberman retatrutide is a glp 1 Gwyneth Paltrow, Andrew & Retatrutide, Retatrutide vs. Tirzepatide, Retatrutide – What if You Could Optimize

and later in 2025 it received FDA approval for obesity

In recent years, GLP-1 receptor agonists first developed as diabetes medications exploded in popularity after researchers discovered they could also dramatically improve weight loss

Adipose tissue NAD+ biology in obesity and insulin resistance: From mechanism to therapy

Simultaneously, it suppresses glucagon secretion from pancreatic alpha cells, reducing hepatic glucose production

Mindful eating practices increase your awareness of hunger and fullness cues, helping you make better food choices

The progression from one receptor (semaglutide) to two (tirzepatide) to three (retatrutide) follows a clear pattern of increasing efficacy